This inventor holds 2 USPTO granted patents. Top assignee: Cangene Corporation. Active years: 1999-2000.
Location History:
- Mississauga, CA (1999)
- Mississuaga, CA (2000)
Company Filing History:
Years Active: 1999-2000
Title: Innovations by Eva Walczyk in Protein Expression
Introduction
Eva Walczyk is a notable inventor based in Mississauga, Canada. She has made significant contributions to the field of protein expression, particularly in bacterial host cells. With a total of 2 patents, her work has advanced the understanding and application of protease inhibitors in biotechnology.
Latest Patents
One of her latest patents is titled "Method for expression of proteins in bacterial host cells." This invention involves the use of an aminopeptidase inhibitor when expressing heterologous proteins in bacterial hosts, such as Streptomyces. The inhibitor plays a crucial role in preventing the degradation of the heterologous protein by aminopeptidases. The design of these inhibitors is based on the mechanism and substrate specificity of the target protease and the expressed protein.
Another significant patent is "Streptomyces proteases and methods for improved secretion of." This patent identifies a family of proteases that are endogenous to Streptomyces cells, which degrade heterologous proteins secreted from these host cells. The proteases include tripeptidyl aminopeptidase-Streptomyces ('Tap') and a Streptomyces protease ('Ssp') that shows significant homology to Subtilisin BPN'. The invention also discusses methods to alleviate degradation by selective inhibition of secreted proteases or by using hosts with impaired protease production capabilities.
Career Highlights
Eva Walczyk is currently employed at Cangene Corporation, where she continues to innovate in the field of biotechnology. Her work has been instrumental in developing methods that enhance protein expression and stability in bacterial systems.
Collaborations
Some of her notable coworkers include Lawrence T Malek and Dany Hadary. Their collaborative efforts contribute to the advancement of research and development in protein expression technologies.
Conclusion
Eva Walczyk's contributions to the field of protein expression through her innovative patents demonstrate her expertise and commitment to advancing biotechnology. Her work continues to influence the industry and pave the way for future innovations.